Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SEPN | Septerna, Inc. | Oct 24, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Director |
BGNE | BeiGene, Ltd. | Sep 30, 2024 | 2 | $0 | 4 | Oct 2, 2024 | Director |
BGNE | BeiGene, Ltd. | Sep 27, 2024 | 0 | $0 | 3 | Oct 2, 2024 | Director |
OGN | Organon & Co. | Jun 7, 2024 | 1 | $200K | 4 | Jun 11, 2024 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 22, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2024 | 3 | -$157K | 4 | May 21, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 4 | $0 | 4 | Jan 23, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $400K | 4 | Jan 3, 2024 | Director |
OGN | Organon & Co. | Jun 9, 2023 | 1 | $200K | 4 | Jun 13, 2023 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director |
OGN | Organon & Co. | Jun 10, 2022 | 1 | $200K | 4 | Jun 14, 2022 | Director |
STRO | SUTRO BIOPHARMA, INC. | Jun 6, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
OGN | Organon & Co. | Jun 4, 2021 | 1 | $327K | 4 | Jun 8, 2021 | Director |
STRO | SUTRO BIOPHARMA, INC. | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |
OGN | Organon & Co. | May 14, 2021 | 0 | $0 | 3 | May 17, 2021 | Director |
DTIL | PRECISION BIOSCIENCES INC | May 10, 2021 | 1 | $0 | 4 | May 12, 2021 | Director |